How to make poison cough syrups

Published Date: 14 Mar 2023

According to market research firm Euromonitor, the global children's cough, cold and allergy products market in 2022 is worth $2.5 billion.

Read Full News

Latest News

One Shot or Two? What to Know About HPV Vaccination Recommendations

— Guidance is evolving

What's Behind Boy's Bullous Skin Lesions After Flu Symptoms?

Mycoplasma pneumonia identified as the culprit in this case of RIME

Meta's $17.1 Billion Settlement: A Chance for a Social Media Natural Experiment

Whether it advances the science depends on who can study the results

CDC, Epidemiologists Work on Definition for Measles Deaths

Standard workgroup process began over the summer

Navigating the Evolving Treatment Landscape in SMA: An Interactive Clinical Decision-Making Simulation

Navigating the Evolving Treatment Landscape in SMA: An Interactive Clinical Decision-Making Simulation

Navigating the Spectrum of SMA: From Genetic Insights to Timely Diagnosis

Navigating the Spectrum of SMA: From Genetic Insights to Timely Diagnosis

Todays Updates

ALOFT-IPF: Admilparant 60 mg Meets Primary FVC End Point

ALOFT-IPF: Admilparant 60 mg Meets Primary FVC End Point

Frontotemporal Dementia Diagnosis, Head Impacts, and Emerging Treatment Approaches Louie Pasculli, Carme Tartaglia, MD

Carmela Tartaglia, MD, FRCPC, discusses the challenges of diagnosing frontotemporal dementia, the evolving role of biomarkers, and emerging approaches to disease modification.

NeurologyLive® Friday 5 — October 9, 2026 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 9, 2026.

Personalizing IgA Nephropathy Care Conversations, With Gaia Coppock, MD Gaia Coppock, MD

Why patients with IgA nephropathy want to understand their disease, not just follow instructions.

ABTECT Maintenance Data Show Durable Remission in UC, With Remo Panaccione, MD Remo Panaccione, MD, FRCPC

Phase 3 ABTECT data show ~51% clinical remission and ≥40% endoscopic remission with obefazimod through week 44.

Where Could Obefazimod Fit in UC Treatment, With Remo Panaccione, MD Remo Panaccione, MD, FRCPC

Obefazimod could work as first, second, or third line therapy in ulcerative colitis ahead of a planned FDA submission this year.

Tezepelumab's TSLP Blockade May Address Refractory EoE Gap Arjan Bredenoord, MD

Arjan Bredenoord, MD, details how tezepelumab's selective TSLP inhibition sustained EoE remission through week 52 of the CROSSING trial.

Todays Updates

ALOFT-IPF: Admilparant 60 mg Meets Primary FVC End Point

ALOFT-IPF: Admilparant 60 mg Meets Primary FVC End Point

Frontotemporal Dementia Diagnosis, Head Impacts, and Emerging Treatment Approaches Louie Pasculli, Carme Tartaglia, MD

Carmela Tartaglia, MD, FRCPC, discusses the challenges of diagnosing frontotemporal dementia, the evolving role of biomarkers, and emerging approaches to disease modification.

NeurologyLive® Friday 5 — October 9, 2026 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 9, 2026.

Personalizing IgA Nephropathy Care Conversations, With Gaia Coppock, MD Gaia Coppock, MD

Why patients with IgA nephropathy want to understand their disease, not just follow instructions.

ABTECT Maintenance Data Show Durable Remission in UC, With Remo Panaccione, MD Remo Panaccione, MD, FRCPC

Phase 3 ABTECT data show ~51% clinical remission and ≥40% endoscopic remission with obefazimod through week 44.

Where Could Obefazimod Fit in UC Treatment, With Remo Panaccione, MD Remo Panaccione, MD, FRCPC

Obefazimod could work as first, second, or third line therapy in ulcerative colitis ahead of a planned FDA submission this year.

Tezepelumab's TSLP Blockade May Address Refractory EoE Gap Arjan Bredenoord, MD

Arjan Bredenoord, MD, details how tezepelumab's selective TSLP inhibition sustained EoE remission through week 52 of the CROSSING trial.

Latest News

— Guidance is evolving

Mycoplasma pneumonia identified as the culprit in this case of RIME

Whether it advances the science depends on who can study the results

Standard workgroup process began over the summer

Navigating the Evolving Treatment Landscape in SMA: An Interactive Clinical Decision-Making Simulation

Navigating the Spectrum of SMA: From Genetic Insights to Timely Diagnosis

News All Time

Vax Beliefs of HHS Deputy Secretary Nominee Probed at Hearing

Chris Klomp praised the MMR vaccine, but Sen. Wyden said Klomp's answers "created confusion"

Inquiry Slams Hospital for Failure to Protect Babies After Nurse's Murder Conviction

Concerns were kept quiet as babies fell ill at hospital where Lucy Letby worked

Twins Conjoined at Head Separated; Brain-Eating Amoeba Source; Mercury-Laden Lotion

Health news and commentary gathered by MedPage Today staff

Where Does Medicine's Responsibility for Human Trafficking End?

Public health is political, but it doesn't have to be partisan, says Nicholas Peoples, MD

RFK Jr. Picks New USPSTF Members

Under Kennedy's scrutiny, the preventive services panel hasn't met in more than a year

Mysterious Stomach Rash Had Unusual Source

It stemmed from prolonged contact with a certain device

RFK Jr. Bolsters Vaccine Skepticism at Children's Health Defense Conference

"We have started to ask the questions that you ... have been asking for years," he said

Doc Running for Congress Calls RFK Jr. 'Dangerous and Incompetent'

Community health and vaccination rates are big issues for California pediatrician

Stuttering: New Consensus Statement Highlights Neurobiology

New consensus guideline frames stuttering as a neurobiological condition, emphasizing that physicians play a crucial role in diagnosis and ongoing management.

NHS Alliance Warns ADHD, Autism Costs Spiralling

NHS leaders say soaring ADHD and autism assessment costs are forcing service cuts and disrupting long-term planning.

Meta Settlement Falls Short on Teen Mental Health Protections, Whistleblower Says

(This August 27 story has been republished to add an image, with no changes to text.)

A Camp for Children With Brain Injuries Zips Ahead

A Pennsylvania camp gives children and young adults with brain injuries a place to connect, but federal funding for traumatic brain injury programs remains uncertain.

Gabapentin Not Linked to Better Outcomes for Kids’ Migraine

For children hospitalized with migraine, gabapentin use wasn’t associated with less pain or fewer readmissions than no use in an observational study.

This 'Natural' Remedy Was Likely Culprit in Baby's Lead Poisoning

Clinicians should ask parents about all meds, traditional and complementary, expert advises

Are Suicide Attempts Contagious in Young People?

— "We know that suicidal behavior does not occur in a social vacuum," researcher says

Dravet Syndrome: Optimizing Early Diagnosis and Treatment Strategies

Dravet Syndrome: Optimizing Early Diagnosis and Treatment Strategies

Recommended News For You

AACR: American Association for Cancer Research

No Laughing Matter: Nitrous Oxide for Transrectal Prostate Biopsy.

Lung Transplant for Lung Cancer: Promising, in Rare Cases

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Cancer detection recovered following pandemic disruptions

Prostate cancer death risk is higher in late teens and early 20s weight gain.

Are ultramarathon runners really at increased risk of bowel cancer?

Recommended Articles For You

Tumor Neighborhoods and Therapy Response: Clinical and Mechanistic Insights 

Demystifying Lymphocytes: Everything You Need to Know  

Beyond the Blood: Expanding CAR T-Cell Therapy to Solid Tumors- A New Era of Precision Oncology 

Clinical Methods in Hematology and Quality Improvement 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Even after a partial ban, asbestos is still used and is a deadly carcinogen, according to the EPA.

2.

Adipocytes in the bone marrow offer early indicators of the development of multiple myeloma from MGUS.

3.

Revolutionary Cancer Tx Could Transform Autoimmune Disease

4.

Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD

5.

Cardiomyocytes are shielded from chemotherapy damage by mitochondrial proteins.

1.

Unlocking the Potential of SCD: A Comprehensive Guide to Diagnosis and Treatment

2.

AI and Optical Advances: Evolving Blood Cell Morphology Observation in Hematology

3.

Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine

4.

Quality of Life Optimization in Long-Term Cancer Survivorship

5.

Feline Anemia: Diagnosis and Treatment with Focus on Rasburicase Complications

1.

International Conference on Oncology, Cardiology and Critical Care Policy

2.

International Conference on Innovations in Critical Care for Oncology and Cardiology

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Cancer Nursing and Hematology Support

1.

Lung Cancer: Risk Factors and Prevention

2.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

3.

Navigating the Complexities of Ph Negative ALL - Part VIII

4.

Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot